Viking Therapeutics, Inc.

VKTX - Company ID 0001607678

Market cap$4.78 B

Rank#1453

Filings627

VKTX income statement (annual)

The table below shows Viking Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$344.95M	$101.64M	$63.81M	$54.23M	$44.98M	$31.93M
SG&A

VKTX annual revenue (10-K history)

Viking Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2025. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.